Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients.

MLA

Liu, Zhendong, et al. “Overexpressed XRCC2 as an Independent Risk Factor for Poor Prognosis in Glioma Patients.” Molecular Medicine, vol. 27, no. 1, May 2021, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s10020-021-00316-0.

APA

Liu, Z., Zhang, W., Cheng, X., Wang, H., Bian, L., Wang, J., Han, Z., Wang, Y., Lian, X., Liu, B., Ren, Z., Zhang, B., Jiang, Z., Lin, Z., & Gao, Y. (2021). Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients. Molecular Medicine, 27(1), 1–15. https://doi.org/10.1186/s10020-021-00316-0

Chicago

Liu, Zhendong, Wang Zhang, Xingbo Cheng, Hongbo Wang, Lu Bian, Jialin Wang, Zhibin Han, et al. 2021. “Overexpressed XRCC2 as an Independent Risk Factor for Poor Prognosis in Glioma Patients.” Molecular Medicine 27 (1): 1–15. doi:10.1186/s10020-021-00316-0.